CEO of Aerie Pharmaceuticals Inc (30-Year Financial, Insider Trades) Vicente Jr Anido (insider trades) bought 26,250 shares of AERI on 09/09/2019 at an average price of $19.01 a share. The total cost of this purchase was $499,012.
Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is engaged in the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie Pharmaceuticals Inc has a market cap of $940.380 million; its shares were traded at around $20.47 with and P/S ratio of 19.03. GuruFocus has detected 4 severe warning signs with Aerie Pharmaceuticals Inc. .
CEO Recent Trades:
- CEO Vicente Jr Anido bought 26,250 shares of AERI stock on 09/09/2019 at the average price of $19.01. The price of the stock has increased by 7.68% since.
CFO Recent Trades:
- CFO Richard J Rubino bought 5,040 shares of AERI stock on 09/09/2019 at the average price of $19.93. The price of the stock has increased by 2.71% since.
Directors and Officers Recent Trades:
- 10% Owner Capital Fund Ii, L.p. Foresite bought 115,900 shares of AERI stock on 09/05/2019 at the average price of $18.47. The price of the stock has increased by 10.83% since.
- 10% Owner Capital Fund Ii, L.p. Foresite bought 75,000 shares of AERI stock on 09/03/2019 at the average price of $21. The price of the stock has decreased by 2.52% since.
- 10% Owner Capital Fund Ii, L.p. Foresite bought 46,153 shares of AERI stock on 08/23/2019 at the average price of $23.45. The price of the stock has decreased by 12.71% since.
- 10% Owner Capital Fund Ii, L.p. Foresite bought 153,847 shares of AERI stock on 08/20/2019 at the average price of $23.88. The price of the stock has decreased by 14.28% since.
- 10% Owner Capital Fund Ii, L.p. Foresite bought 539,555 shares of AERI stock on 08/14/2019 at the average price of $24.73. The price of the stock has decreased by 17.23% since.
For the complete insider trading history of AERI, click here
.
